Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Return on Invested Capital (2018 - 2025)

Historic Return on Invested Capital for Enanta Pharmaceuticals (ENTA) over the last 12 years, with Q3 2025 value amounting to 1.16%.

  • Enanta Pharmaceuticals' Return on Invested Capital fell 3000.0% to 1.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.16%, marking a year-over-year decrease of 3000.0%. This contributed to the annual value of 0.86% for FY2025, which is 1700.0% down from last year.
  • As of Q3 2025, Enanta Pharmaceuticals' Return on Invested Capital stood at 1.16%, which was down 3000.0% from 1.09% recorded in Q2 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Return on Invested Capital registered a high of 0.21% during Q1 2021, and its lowest value of 1.16% during Q3 2025.
  • For the 5-year period, Enanta Pharmaceuticals' Return on Invested Capital averaged around 0.59%, with its median value being 0.54% (2023).
  • Per our database at Business Quant, Enanta Pharmaceuticals' Return on Invested Capital plummeted by -1000bps in 2022 and then tumbled by -3300bps in 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.3% in 2021, then plummeted by -33bps to 0.4% in 2022, then plummeted by -79bps to 0.71% in 2023, then dropped by -28bps to 0.9% in 2024, then decreased by -29bps to 1.16% in 2025.
  • Its Return on Invested Capital was 1.16% in Q3 2025, compared to 1.09% in Q2 2025 and 0.97% in Q1 2025.